Cargando…

Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study

BACKGROUND: The hemoglobin glycation index (HGI) was developed to quantify glucose metabolism and individual differences and proved to be a robust measure of individual glycosylated hemoglobin (HbA1c) bias. Here, we aimed to explore the relationship between different HGIs and the risk of 5-year majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhan, Liu, Hongzhou, Hu, Xiaodong, Wang, Anping, Wang, Anning, Kang, Shaoyang, Zhang, Lingjing, Gu, Weijun, Dou, Jingtao, Mu, Yiming, Chen, Kang, Wang, Weiqing, Lyu, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586840/
https://www.ncbi.nlm.nih.gov/pubmed/37265382
http://dx.doi.org/10.1097/CM9.0000000000002717
_version_ 1785123229224927232
author Wang, Yuhan
Liu, Hongzhou
Hu, Xiaodong
Wang, Anping
Wang, Anning
Kang, Shaoyang
Zhang, Lingjing
Gu, Weijun
Dou, Jingtao
Mu, Yiming
Chen, Kang
Wang, Weiqing
Lyu, Zhaohui
author_facet Wang, Yuhan
Liu, Hongzhou
Hu, Xiaodong
Wang, Anping
Wang, Anning
Kang, Shaoyang
Zhang, Lingjing
Gu, Weijun
Dou, Jingtao
Mu, Yiming
Chen, Kang
Wang, Weiqing
Lyu, Zhaohui
author_sort Wang, Yuhan
collection PubMed
description BACKGROUND: The hemoglobin glycation index (HGI) was developed to quantify glucose metabolism and individual differences and proved to be a robust measure of individual glycosylated hemoglobin (HbA1c) bias. Here, we aimed to explore the relationship between different HGIs and the risk of 5-year major adverse cardiovascular events (MACEs) by performing a large multicenter cohort study in China. METHODS: A total of 9791 subjects from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: a Longitudinal Study (the REACTION study) were divided into five subgroups (Q1–Q5) with the HGI quantiles (≤5th, >5th and ≤33.3th, >33.3th and ≤66.7th, >66.7th and ≤95th, and >95th percentile). A multivariate logistic regression model constructed by the restricted cubic spline method was used to evaluate the relationship between the HGI and the 5-year MACE risk. Subgroup analysis between the HGI and covariates were explored to detect differences among the five subgroups. RESULTS: The total 5-year MACE rate in the nationwide cohort was 6.87% (673/9791). Restricted cubic spline analysis suggested a U-shaped correlation between the HGI values and MACE risk after adjustment for cardiovascular risk factors (χ(2) = 29.5, P <0.001). After adjustment for potential confounders, subjects with HGIs ≤–0.75 or >0.82 showed odds ratios (ORs) for MACE of 1.471 (95% confidence interval [CI], 1.027–2.069) and 2.222 (95% CI, 1.641–3.026) compared to subjects with HGIs of >–0.75 and ≤–0.20. In the subgroup with non-coronary heart disease, the risk of MACE was significantly higher in subjects with HGIs ≤–0.75 (OR, 1.540 [1.039–2.234]; P = 0.027) and >0.82 (OR, 2.022 [1.392–2.890]; P <0.001) compared to those with HGIs of ≤–0.75 or >0.82 after adjustment for potential confounders. CONCLUSIONS: We found a U-shaped correlation between the HGI values and the risk of 5-year MACE. Both low and high HGIs were associated with an increased risk of MACE. Therefore, the HGI may predict the 5-year MACE risk.
format Online
Article
Text
id pubmed-10586840
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105868402023-10-20 Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study Wang, Yuhan Liu, Hongzhou Hu, Xiaodong Wang, Anping Wang, Anning Kang, Shaoyang Zhang, Lingjing Gu, Weijun Dou, Jingtao Mu, Yiming Chen, Kang Wang, Weiqing Lyu, Zhaohui Chin Med J (Engl) Original Article BACKGROUND: The hemoglobin glycation index (HGI) was developed to quantify glucose metabolism and individual differences and proved to be a robust measure of individual glycosylated hemoglobin (HbA1c) bias. Here, we aimed to explore the relationship between different HGIs and the risk of 5-year major adverse cardiovascular events (MACEs) by performing a large multicenter cohort study in China. METHODS: A total of 9791 subjects from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: a Longitudinal Study (the REACTION study) were divided into five subgroups (Q1–Q5) with the HGI quantiles (≤5th, >5th and ≤33.3th, >33.3th and ≤66.7th, >66.7th and ≤95th, and >95th percentile). A multivariate logistic regression model constructed by the restricted cubic spline method was used to evaluate the relationship between the HGI and the 5-year MACE risk. Subgroup analysis between the HGI and covariates were explored to detect differences among the five subgroups. RESULTS: The total 5-year MACE rate in the nationwide cohort was 6.87% (673/9791). Restricted cubic spline analysis suggested a U-shaped correlation between the HGI values and MACE risk after adjustment for cardiovascular risk factors (χ(2) = 29.5, P <0.001). After adjustment for potential confounders, subjects with HGIs ≤–0.75 or >0.82 showed odds ratios (ORs) for MACE of 1.471 (95% confidence interval [CI], 1.027–2.069) and 2.222 (95% CI, 1.641–3.026) compared to subjects with HGIs of >–0.75 and ≤–0.20. In the subgroup with non-coronary heart disease, the risk of MACE was significantly higher in subjects with HGIs ≤–0.75 (OR, 1.540 [1.039–2.234]; P = 0.027) and >0.82 (OR, 2.022 [1.392–2.890]; P <0.001) compared to those with HGIs of ≤–0.75 or >0.82 after adjustment for potential confounders. CONCLUSIONS: We found a U-shaped correlation between the HGI values and the risk of 5-year MACE. Both low and high HGIs were associated with an increased risk of MACE. Therefore, the HGI may predict the 5-year MACE risk. Lippincott Williams & Wilkins 2023-06-02 2023-10-20 /pmc/articles/PMC10586840/ /pubmed/37265382 http://dx.doi.org/10.1097/CM9.0000000000002717 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Wang, Yuhan
Liu, Hongzhou
Hu, Xiaodong
Wang, Anping
Wang, Anning
Kang, Shaoyang
Zhang, Lingjing
Gu, Weijun
Dou, Jingtao
Mu, Yiming
Chen, Kang
Wang, Weiqing
Lyu, Zhaohui
Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title_full Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title_fullStr Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title_full_unstemmed Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title_short Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study
title_sort association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the reaction cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586840/
https://www.ncbi.nlm.nih.gov/pubmed/37265382
http://dx.doi.org/10.1097/CM9.0000000000002717
work_keys_str_mv AT wangyuhan associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT liuhongzhou associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT huxiaodong associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT wanganping associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT wanganning associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT kangshaoyang associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT zhanglingjing associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT guweijun associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT doujingtao associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT muyiming associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT chenkang associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT wangweiqing associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy
AT lyuzhaohui associationbetweenhemoglobinglycationindexand5yearmajoradversecardiovasculareventsthereactioncohortstudy